Sort
17,288 grants matching “multiple sclerosis”
The curious case of Wnt effector TCF712 in CNS myelination and remyelination
$235,188Fuzheng Guo · University Of California At Davis · R21 · FY2016 · NS
LFA-1 in Lymphocyte Migration
$235,048Minsoo Kim · University Of Rochester · R01 · FY2009 · HL
University of Pennsylvania Clinical Autoimmunity Center of Excellence
$235,009Aimee S Payne · University Of Pennsylvania · UM1 · FY2019 · AI
Validation of Diffusion Basis Spectrum Imaging of Neuroinflammation in Schizophrenia
$235,001Daniel Mamah · Washington University · R21 · FY2023 · MH
Uncoupling Oligodendrocyte Differentiation and Myelination: Axon Signaling Not Required
$234,968Sonia R Mayoral · Brown University · K22 · FY2021 · NS
Frontal White Matter and Impulsivity in Schizophrenia
$234,967Matthew J Hoptman · Nathan S. Kline Institute For Psych Res · R01 · FY2007 · MH
Immunoregulatory effect of microparticle delivered STING agonist in the control of experimental autoimmune encephalomyelitis (EAE) and multiple sclerosis (MS)
$234,966Silva Markovic-Plese · Thomas Jefferson University · R21 · FY2021 · AI
Astrocyte regulation of CNS remyelination
$234,927Gareth R John · Icahn School Of Medicine At Mount Sinai · R01 · FY2010 · NS
Tracking the invaders in multiple sclerosis: Highly specific TREM1-targeted PET imaging of toxic infiltrating myeloid cells and early treatment response.
$234,910Michelle Louise James · Stanford University · R21 · FY2019 · NS
Statistical Methods for Analysis of Failure Time Data
$234,874Rebecca A. Betensky · Harvard School Of Public Health · R01 · FY2009 · CA
Computer Based Sequence Analysis and RNA Virus Evolution
$234,794Marcella A McClure · Montana State University - Bozeman · R01 · FY2007 · AI
Alpha M Beta 2 integrin blockade for acute inflammatory neuropathies
$234,750Eroboghene Ekamereno Ubogu · Baylor College Of Medicine · R21 · FY2012 · NS
Fibronectin peptide antagonism for chronic inflammatory neuropathies
$234,750Eroboghene Ekamereno Ubogu · Baylor College Of Medicine · R21 · FY2011 · NS
Identification of a novel resistance gene for demyelinating disease
$234,750Elizabeth P. Blankenhorn · Drexel University · R21 · FY2017 · AI
Injectable Biomaterial Scaffold for Inducing Antigen-Specific Tolerance
$234,750Hao Cheng · Drexel University · R21 · FY2017 · AI
Role of soluble TREM2 and its R47H and D87N variants in neurodegenerative disease
$234,750Steven G Younkin · Mayo Clinic Jacksonville · R21 · FY2014 · NS
Targeting Cytolytic Cells to Lymphoid Sites of HIV Persistence.
$234,742Michael Marcel Lederman · Case Western Reserve University · R21 · FY2014 · AI
NR/CAM AND FORMATION OF NODE OF RANVIER
$234,643Rutgers The St Univ Of Nj New Brunswick · R01 · FY2001 · NS
Development of neuroprotective PDZ-domain inhibitors for the treatment of MS
$234,568John Marshall · Brown University · R21 · FY2008 · NS
Clinical and Biorepository Core
$234,491Robyn Therese Domsic · University Of Pittsburgh At Pittsburgh · P50 · FY2025 · AR
Cell epigenetics & communication in systemic sclerosis and localized scleroderma skin disease
$234,490Robert A Lafyatis · University Of Pittsburgh At Pittsburgh · P50 · FY2025 · AR
From proteomics and genomics to therapeutics in systemic sclerosis interstitial lung disease
$234,488Oliver Eickelberg · University Of Pittsburgh At Pittsburgh · P50 · FY2025 · AR
The Role of APOE Signaling in Microglia in Glaucoma
$234,328Milica Margeta · Massachusetts Eye And Ear Infirmary · K08 · FY2020 · EY
The Role of APOE Signaling in Microglia in Glaucoma
$234,328Milica Margeta · Massachusetts Eye And Ear Infirmary · K08 · FY2021 · EY
The Role of APOE Signaling in Microglia in Glaucoma
$234,328Milica Margeta · Massachusetts Eye And Ear Infirmary · K08 · FY2019 · EY